title: [Hexamethylene bisacetamide (HMBA) prevents the loss of porcine thyroid monolayer cells to thyrotropin sensitivity].
abstract: The polar compound hexamethylenebisacetamide (HMBA) is a differentiating agent in the murine erythroleukemia cell system (MELC). It induces, like dimethylsulfoxide, the commitment to terminal differentiation leading to a recovery in the expression of several genes like the globin gene. This molecule which also induces differentiation in other cellular types is a growth agent for human, ovine and porcine thyroid cells. Forty-eight hours after the onset of culture, porcine thyroid monolayer cells do not respond to thyrotropin (TSH). We demonstrate that a pretreatment from the onset of culture with HMBA of porcine thyroid cells prevents the loss of TSH-sensitivity. The TSH-sensitivity is concentration-dependent in HMBA and leads to the reorganization of cells into follicles, even in the presence of HMBA. However, the withdrawal of HMBA when TSH is added is absolutely required to obtain a total recovery in iodide trapping and organification. If HMBA is present during TSH-stimulation, it inhibits iodide trapping partially but iodide organification completely Cells remain sensitive to TSH for at least 12 days if HMBA treated, and their sensitivity is totally restored after 3, 6 or 9 days of TSH-stimulation. HMBA, which is, like TSH, a growth agent for the thyroid cell and an agent that maintains some of the specialized functions, could be a putative candidate to obtain normal human thyroid cell lines.
authors.affiliation: Laboratoire de biochimie médicale et unité 38 de l'Inserm, faculté de médecine, Marseille, France.
authors.forename: T
authors.initials: T
authors.lastname: Amphoux-Fazekas
authors.forename: G
authors.initials: G
authors.lastname: Fayet
authors.forename: S
authors.initials: S
authors.lastname: Hovsépian
authors.forename: A
authors.initials: A
authors.lastname: Aouani
authors.forename: N
authors.initials: N
authors.lastname: Samih
mesh_terms: D000081:Acetamides / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D002454:Cell Differentiation / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D006801:Humans; D018377:Neurotransmitter Agents / Q000494:pharmacology*; D012756:Sheep; D013552:Swine; D013961:Thyroid Gland / Q000166:cytology* / Q000187:drug effects*; D013972:Thyrotropin / Q000494:pharmacology*; D013997:Time Factors
chemical_list: D000081:Acetamides; D018377:Neurotransmitter Agents; D013972:Thyrotropin; C014026:hexamethylene bisacetamide
vernacular_title: L'hexaméthylène bisacétamide (HMBA) supprime la perte de sensibilité des cellules thyroïdiennes monocouches de porc à la thyrotropine.